OverviewSuggest Edit

    ERT is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions in centralized Cardiac Safety, Respiratory, Suicide Risk Assessment, electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products. 

    HQPhiladelphia, PA, US
    Employee Ratings2.9
    Overall CultureC-

    Latest Updates

    Employees (est.) (Feb 2021)2,728
    Cybersecurity ratingBMore

    Key People/Management at ERT

    James Corrigan

    James Corrigan

    President & Chief Exective Officer
    Joe Eazor

    Joe Eazor

    President and CEO
    Waqar Nasim

    Waqar Nasim

    EVP, Chief Financial Officer
    Tom Vadaketh

    Tom Vadaketh

    EVP, Chief Financial Officer
    Andrew Cooper

    Andrew Cooper

    EVP, Chief Commercial Officer
    Bob Shambaugh

    Bob Shambaugh

    Chief Operating Officer, Executive Vice President
    Show more

    ERT Office Locations

    ERT has offices in Philadelphia, Boston, Bridgewater, Bristol and in 14 other locations
    Philadelphia, PA, US (HQ)
    1818 Market Street, 1818 Market St
    Boston, MA, US
    500 Rutherford Ave
    Bridgewater, NJ, US
    685 US-202
    Bridgewater, NJ, US
    685 US-206
    Bristol, PA, US
    1501 Grundy Ln Suite A
    Cleveland, OH, US
    1111 Superior Ave
    Show all (19)

    ERT Financials and Metrics

    Summary Metrics

    Founding Date


    ERT Acquisitions / Subsidiaries

    Company NameDateDeal Size
    iCardiac TechnologiesDecember 04, 2017

    ERT Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    ERT Online and Social Media Presence

    Embed Graph

    ERT Company Culture

    • Overall Culture



    • CEO Rating



    • Compensation



    Learn more on Comparably

    ERT News and Updates

    ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology

    PHILADELPHIA, Dec. 10, 2020 /PRNewswire/ -- ERT, a global leader in clinical end-point data solutions, today announced that Bioclinica, a technological and scientific leader in clinical imaging, has agreed to merge with ERT. This combination will create a leading partner to global...

    ERT and Science 37® Partner to Deliver High-Quality Data during Virtual Trials

    PHILADELPHIA and LOS ANGELES, Aug. 25, 2020 /PRNewswire/ -- ERT, the global leader in clinical endpoint data collection, and Science 37, the leader in decentralized clinical trials, today announced a partnership enabling ERT's Cardiac Safety, Respiratory, and Imaging solutions to be...

    E-Clinical Solution Software Market Size, Status and Forecast 2019-2025: Oracle, Merge Healthcare, Medidata Solutions, PAREXEL International, BioClinica, ERT

    The qualitative research study conducted by HTF MI titled “Global E-Clinical Solution Software Market Size, Status and Forecast 2019-2025” provides primary Data, surveys, Scope of the Product and vendor briefings. Posted via Industry Today. Follow us on Twitter @IndustryToday

    Global Clinical Trial Imaging Market Growth, Development and Key Manufacturer Analysis Report 2019-2025 PAREXEL International Corporation, ICON plc, IXICO plc, Intrinsic Imaging, LLC, ERT Clinical, BioTelemetry, Inc., Cardiovascular Imaging Technologies,

    This report provides an in-depth insight of global Clinical Trial Imaging industry covering all necessary parameters together with development trends, challenges, opportunities, key manufacturers and competitive analysis. Posted via Industry Today. Follow us on Twitter @IndustryToday

    Cognitive Assessment Global Market 2018-2025: Cambridge Cognition, Cognifit, Cogstate, ERT Clinical, Groupe SBT

    Wiseguyreports.Com Publish New Market Research Report On -“Cognitive Assessment Market - Global Industry Analysis, Size, Share, Trends, Growth and Forecast 2018 - 2025” Posted via Industry Today. Follow us on Twitter @IndustryToday

    LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Rockwell Medical, Inc. To Contact The Firm

    NEW YORK, Aug. 16, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Rockwell Medical, Inc. ("Rockwell" or the "Company") (NASDAQ: RMTI) of the September 25, 2018 deadline to seek the role of lead plaintiff in a federal securities...
    Show more

    ERT Blogs

    Partnerships in Clinical Trials Europe

    Join us in Barcelona, Spain for our presentations, “BYOD: A Game-Changer for Sponsors, Sites and Patients," “Beyond Risk-based Monitoring: Employing Risk-based Management," and attend our debate, "What single activity will change our industry the most by 2030?" The post Partnerships in Clinical Tria…

    Why Early Phase Cardiac Safety Assessment Makes Good Business Sense

    Learn how determining the cardiac safety profile of your compound by assessing QT during routine Phase I studies enables you to make go/no-go decisions sooner, better prioritize your drug development pipeline, and appropriately resource or refocus programs exhibiting potential cardiac safety issues.…

    Putting Patients First – Building Adaptive Digital Health Programs

    This article reviews how the ERT/Foundry3 collaboration is delivering rich, adaptive digital health programs ─ based on substantiated patient needs ─ to help patients better manage their conditions and ultimately improve health outcomes. The post Putting Patients First – Building Adaptive Digital He…

    5th Clinical Trials Phase I & Phase IIA Summit

    oin Brian Smith, VP, Operations, ERT as he presents, “Optimizing ECG Collection in Phase 1 Studies,” at ExL Events’ Clinical Trials Phase I & IIA Summit this October. The post 5th Clinical Trials Phase I & Phase IIA Summit appeared first on ERT.

    Outsourcing in Clinical Trials – Southern CA

    Oncology trials are complex and prone to variability ― assessment of tumor response is typically unstructured, prone to errors, and inefficient. Join Amit Vasanji, PhD, ERT's Chief Technology Officer for Imaging, as he presents, “Leveraging Technology to Manage Risk in Imaging Scoring Systems.” The …

    DPharm: Disruptive Innovations to Advance Clinical Trials

    Precision medicine, patient centricity and big data bring increasing complexity to clinical trials — complexity that requires novel approaches and new technologies to support success. Voice assistant technology and artificial intelligence (AI), including machine learning, will become the norm in th…
    Show more

    ERT Frequently Asked Questions

    • When was ERT founded?

      ERT was founded in 1972.

    • Who are ERT key executives?

      ERT's key executives are James Corrigan, Joe Eazor and Waqar Nasim.

    • How many employees does ERT have?

      ERT has 2,728 employees.

    • Who are ERT competitors?

      Competitors of ERT include BioClinica, Immucor and Veterans Evaluation Services.

    • Where is ERT headquarters?

      ERT headquarters is located at 1818 Market Street, 1818 Market St, Philadelphia.

    • Where are ERT offices?

      ERT has offices in Philadelphia, Boston, Bridgewater, Bristol and in 14 other locations.

    • How many offices does ERT have?

      ERT has 19 offices.